Gabriel Mateus Bernardo Harrington
A Comprehensive Proteomic and Bioinformatic Analysis of Human Spinal Cord Injury Plasma Identifies Proteins Associated with the Complement Cascade and Liver Function as Potential Prognostic Indicators of Neurological Outcome
Mateus Bernardo Harrington, Gabriel; Cool, Paul; Hulme, Charlotte; Fisher-Stokes, Jessica; Peffers, Mandy; El Masri, Wagih; Osman, Aheed; Roy Chowdhury, Joy; Kumar, Naveen; Budithi, Srinivasa; Wright, Karina
Authors
Professor Wim Cool p.cool@keele.ac.uk
Charlotte Hulme c.hulme1@keele.ac.uk
Jessica Fisher-Stokes
Mandy Peffers
Wagih El Masri
Aheed Osman
Joy Roy Chowdhury
Naveen Kumar
Srinivasa Budithi
Karina Wright k.t.wright@keele.ac.uk
Abstract
Spinal cord injury (SCI) is a major cause of disability, with complications postinjury often leading to lifelong health issues with the need for extensive treatment. Neurological outcome post-SCI can be variable and difficult to predict, particularly in incompletely injured patients. The identification of specific SCI biomarkers in blood may be able to improve prognostics in the field. This study has utilized proteomic and bioinformatic methodologies to investigate differentially expressed proteins in plasma samples across human SCI cohorts with the aim of identifying candidate prognostic biomarkers and biological pathway alterations that relate to neurological outcome. Blood samples were taken, following informed consent, from American Spinal Injury Association impairment scale (AIS) grade C “improvers” (those who experienced an AIS grade improvement) and “nonimprovers” (no AIS change) and AIS grade A and D at <2 weeks (“acute”) and ∼3 months (“subacute”) postinjury. The total protein concentration from each sample was extracted, with pooled samples being labeled and nonpooled samples treated with ProteoMiner™ beads. Samples were then analyzed using two 4-plex isobaric tag for relative and absolute quantification (iTRAQ) analyses and a label-free experiment for comparison before quantifying with mass spectrometry. Data are available via ProteomeXchange with identifiers PXD035025 and PXD035072 for the iTRAQ and label-free experiments, respectively. Proteomic datasets were analyzed using OpenMS (version 2.6.0). R (version 4.1.4) and, in particular, the R packages MSstats (version 4.0.1) and pathview (version 1.32.0) were used for downstream analysis. Proteins of interest identified from this analysis were further validated by enzyme-linked immunosorbent assay. The data demonstrated proteomic differences between the cohorts, with the results from the iTRAQ approach supporting those of the label-free analysis. A total of 79 and 87 differentially abundant proteins across AIS and longitudinal groups were identified from the iTRAQ and label-free analyses, respectively. Alpha-2-macroglobulin, retinol-binding protein 4 (RBP4), serum amyloid A1, peroxiredoxin 2 (PRX-2), apolipoprotein A1, and several immunoglobulins were identified as biologically relevant and differentially abundant, with potential as individual candidate prognostic biomarkers of neurological outcome. Bioinformatics analyses revealed that the majority of differentially abundant proteins were components of the complement cascade and most interacted directly with the liver. Many of the proteins of interest identified using proteomics were detected only in a single group and therefore have potential as binary (present or absent) biomarkers, RBP4 and PRX-2 in particular. Additional investigations into the chronology of these proteins and their levels in other tissues (cerebrospinal fluid in particular) are needed to better understand the underlying pathophysiology, including any potentially modifiable targets. Pathway analysis highlighted the complement cascade as being significant across groups of differential functional recovery.
Citation
Mateus Bernardo Harrington, G., Cool, P., Hulme, C., Fisher-Stokes, J., Peffers, M., El Masri, W., Osman, A., Roy Chowdhury, J., Kumar, N., Budithi, S., & Wright, K. (2025). A Comprehensive Proteomic and Bioinformatic Analysis of Human Spinal Cord Injury Plasma Identifies Proteins Associated with the Complement Cascade and Liver Function as Potential Prognostic Indicators of Neurological Outcome. Journal of Neurotrauma, 42(3-4), 292-306. https://doi.org/10.1089/neu.2023.0064
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 5, 2024 |
Online Publication Date | Feb 17, 2025 |
Publication Date | Feb 1, 2025 |
Deposit Date | Feb 26, 2025 |
Publicly Available Date | Feb 26, 2025 |
Journal | Journal of Neurotrauma |
Print ISSN | 0897-7151 |
Electronic ISSN | 1557-9042 |
Publisher | Mary Ann Liebert |
Peer Reviewed | Peer Reviewed |
Volume | 42 |
Issue | 3-4 |
Pages | 292-306 |
DOI | https://doi.org/10.1089/neu.2023.0064 |
Public URL | https://keele-repository.worktribe.com/output/1013535 |
Publisher URL | https://www.liebertpub.com/doi/10.1089/neu.2023.0064 |
Files
A comprehensive proteomic and bioinformatic analysis of human spinal cord injury plasma identifies proteins associated with the complement cascade and liver function as potential prognostic indicators of neurological outcome
(47 Kb)
Document
Licence
https://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
This accepted manuscript is licensed under the Creative Commons Attribution 4.0 licence. https://creativecommons.org/licenses/by/4.0/
You might also like
Genomic Sequencing to Diagnose Prosthetic Joint Infection in the Knee: A Case Report
(2023)
Journal Article
The impact and efficacy of surveillance in patients with sarcoma of the extremities
(2017)
Journal Article
Osteobastoma of the Talus: A case report and review of the literature
(2017)
Journal Article
Lesson of the month 2: Oncology, obstetrics and orthopaedics: an unusual partnership
(2016)
Journal Article
Surveillance of intramedullary cartilage tumours in long bones
(2016)
Journal Article